Tetrahydrofuran → HCID 86722460, compound
Reaction equation
[Li]CCCC.Br[C:7]1[C:15]2[N:14]([C:16]3[CH:21]=[CH:20][C:19]([F:22])=[CH:18][CH:17]=3)[N:13]=[CH:12][C:11]=2[CH:10]=[C:9]2[C:23]3([CH2:37][CH3:38])[CH2:31][CH2:30][C:29]([C:33]([F:36])([F:35])[F:34])([OH:32])[CH2:28][CH:24]3[CH2:25][CH2:26][O:27][C:8]=12.C1COCC1>CO>[CH2:37]([C@:23]12[CH2:31][CH2:30][C@:29]([C:33]([F:35])([F:36])[F:34])([OH:32])[CH2:28][C@@H:24]1[CH2:25][CH2:26][O:27][C:8]1[C:9]2=[CH:10][C:11]2[CH:12]=[N:13][N:14]([C:16]3[CH:17]=[CH:18][C:19]([F:22])=[CH:20][CH:21]=3)[C:15]=2[CH:7]=1)[CH3:38].[CH2:37]([C@@:23]12[CH2:31][CH2:30][C@@:29]([C:33]([F:35])([F:36])[F:34])([OH:32])[CH2:28][C@H:24]1[CH2:25][CH2:26][O:27][C:8]1[C:9]2=[CH:10][C:11]2[CH:12]=[N:13][N:14]([C:16]3[CH:17]=[CH:18][C:19]([F:22])=[CH:20][CH:21]=3)[C:15]=2[CH:7]=1)[CH3:38]Participants
Reactant 3
Product 1
Reagents, catalysts & solvents 1
Procedure
n-BuLi (1.6 M solution in hexanes, 0.900 mL, 1.440 mmol) was added dropwise to a solution of 3R,4aR,12bR)-8-bromo-12b-ethyl-9-(4-fluorophenyl)-3-(trifluoromethyl)-2,3,4,4a,5,6,9,12b-octahydro-1H-benzo[4,5]oxepino[3,2-f]indazol-3-ol; compound with 3S,4aS,12bS)-8-bromo-12b-ethyl-9-(4-fluorophenyl)-3-(trifluoromethyl)-2,3,4,4a,5,6,9,12b-octahydro-1H-benzo[4,5]oxepino[3,2-f]indazol-3-ol (108, R1=4-Fluorophenyl, R2=Ethyl, R3=Trifluoromethyl) (0.364 g, 0.690 mmol) and THF (10.0 mL) under a nitrogen atmosphere at about −78° C. After about 45 min, n-BuLi (1.6 M solution in hexanes, 0.100 mL, 0.160 mmol) was added dropwise over about 2 min. After about 30 min, MeOH (0.4 mL) was added dropwise. The cold bath was removed. Sat. aq. NH4Cl (20 mL), water (5 mL) and EtOAc (20 mL) were added. The layers were separated and the organics were dried over Na2SO4, filtered and concentrated under reduced pressure. The residue was purified on silica gel (40 g) using a gradient of 0-2% EtOAc in DCM. The fractions containing the product were combined and concentrated under reduced pressure to afford (3R,4aR,12bR)-12b-ethyl-9-(4-fluorophenyl)-3-(trifluoromethyl)-2,3,4,4a,5,6,9,12b-octahydro-1H-benzo[4,5]oxepino[3,2-f]indazol-3-ol; compound with (3S,4aS,12bS)-12b-ethyl-9-(4-fluorophenyl)-3-(trifluoromethyl)-2,3,4,4a,5,6,9,12b-octahydro-1H-benzo[4,5]oxepino[3,2-f]indazol-3-ol (109, R1=4-Fluorophenyl, R2=Ethyl, R3=Trifluoromethyl) (0.273 g, 88% yield) of an ivory solid. LC/MS, method 2, Rt=2.77 min, MS m/z 449 (M+H)+. 1H NMR (400 MHz, DMSO) δ 8.27 (d, J=1.0 Hz, 1H), 7.82-7.74 (m, 3H), 7.44-7.36 (m, 2H), 7.31 (d, J=0.9 Hz, 1H), 5.91 (s, 1H), 4.45-4.34 (m, 1H), 3.60-3.47 (m, 1H), 2.40-2.25 (m, 1H), 2.23-1.49 (m, 10H), 0.38 (t, J=7.4 Hz, 3H).
Workup
- customat about −78° C
- waitAfter about 30 min
- customThe cold bath was removed
- additionSat. aq. NH4Cl (20 mL), water (5 mL) and EtOAc (20 mL) were added
- customThe layers were separated
- dry with materialthe organics were dried over Na2SO4
- filtrationfiltered
- concentrationconcentrated under reduced pressure
- customThe residue was purified on silica gel (40 g)
- additionThe fractions containing the product
- concentrationconcentrated under reduced pressure
Sources & evidence
- ORD record
- ord-f24c6abcd9234dbd9e2ecb9b66934ce0
- Source dataset
- uspto-grants-2015_11
- Patent number
- US09193744B2
Reaction notes
Loading…